Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2005
10/04/2005US6951755 Vectors and methods for gene transfer
10/04/2005US6951754 Expression vector for use as transformation and gene expression tool in genetic engineering
10/04/2005US6951753 Helper-free stocks of recombinant adeno-associated virus vectors
10/04/2005US6951750 Prolidase and its gene and method for producing prolidase
10/04/2005US6951749 Carboxypeptidases and nucleic acids encoding same
10/04/2005US6951745 Polyhydroxyalkanoate-containing structure and manufacturing method thereof
10/04/2005US6951744 Nucleotide sequence amplification; obtain nucleotide sequences, incubate with reaction mixture, digest with pyrophosphatase, amplify nucleotide sequences
10/04/2005US6951742 Polyclonal and monoclonal antibodies to antigens in poultry or birds, formed using polynucleotide vaccines; proteomics
10/04/2005US6951741 Host/vector system for expression of membrane proteins
10/04/2005US6951740 Comprises expression vector for transfection and expression of thrombopoietin in cell; bioreactors and heterologous polypeptide expression
10/04/2005US6951738 Human tumor necrosis factor receptors TR13 and TR14
10/04/2005US6951737 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/04/2005US6951735 Death domain containing receptors
10/04/2005US6951734 Generate protein for X-ray crystallographic analysis; obtain cell extract, incubate with protein synthesis mixture and label, detect signal from preferential protein
10/04/2005US6951732 Virulence genes, proteins, and their use
10/04/2005US6951720 Use of phosphorothiolate polynucleotides in ligating nucleic acids
10/04/2005US6951719 Polynucleotides formed by hybridization of oligonucleotides, then ligation with synthetases and denaturing to form complementary DNA; genetic engineering
10/04/2005US6951718 rpoB gene fragments and a method for the diagnosis and identification of Mycobacterium tuberculosis and non-tuberculosis Mycobacterial strains
10/04/2005US6951717 Methods and compositions for inhibition of membrane fusion-associated events, including HIV transmission
10/04/2005US6951682 Porous coatings bearing ligand arrays and use thereof
10/04/2005US6951653 Streptococcal C5a peptidase vaccine
10/04/2005US6951651 CTL epitope analogs
10/04/2005US6951650 Antigenic class of avian reoviruses
10/04/2005US6951649 Methods of making neuraminidase-supplemented compositions
10/04/2005US6951646 recognizing conformation dependent epitopes of HCV glycoprotein E2 that are capable of neutralizing the binding of E2 protein onto susceptible cells
10/04/2005CA2244204C A plant nuclear scaffold attachment region which increases gene expression
10/04/2005CA2105304C Inhibitors of human neutrophil elastase and human cathepsin g
09/2005
09/30/2005CA2499791A1 Angptl4/fiaf as marker for ppardelta modulation
09/30/2005CA2460437A1 Crh and pomc effects on animal growth
09/29/2005WO2005090997A1 Method of agitating solution
09/29/2005WO2005090996A1 Sirt6 transgenic non-human animals and assay methods
09/29/2005WO2005090991A1 Adam8 as tumor marker and therapeutic target for non-small cell lung cancer
09/29/2005WO2005090982A1 Detection method with the use of polyhedrosis protein complex
09/29/2005WO2005090977A1 C20orf23 as modifier of the igfr pathway and methods of use
09/29/2005WO2005090976A1 Pdes as modifiers of the igfr pathway and methods of use
09/29/2005WO2005090968A1 Tat-based immunomodulatory compositions and methods of their discovery and use
09/29/2005WO2005090607A1 Methods and compositions for generating and amplifying dna libraries for sensitive detection and analysis of dna methylation
09/29/2005WO2005090606A2 Identification of toxic nucleotide sequences
09/29/2005WO2005090604A1 Method of detecting gene mutation and kit for detecting gene mutation
09/29/2005WO2005090599A2 Methods and adaptors for analyzing specific nucleic acid populations
09/29/2005WO2005090590A1 Method for producing l-amino acids from d-amino acids
09/29/2005WO2005090585A1 Solid phase gene transfer method using virus vector, composition for the method and apparatus for the method
09/29/2005WO2005090584A2 Influenza vaccine based on fowl plague viruses
09/29/2005WO2005090583A1 Genetically modified plants and their applications in phytoremediation.
09/29/2005WO2005090582A1 Post harvest control of genetically modified crop growth employing d-amino acid compounds
09/29/2005WO2005090581A1 Improved constructs for marker excision based on dual-function selection marker
09/29/2005WO2005090580A1 Using nonhuman animal model, method of measuring transcription activity, method of measuring cell quantity and method of measuring tumor volume
09/29/2005WO2005090579A1 Modified bouganin proteins, cytotoxins and methods and uses thereof
09/29/2005WO2005090578A1 Sclerotinia resistance gene
09/29/2005WO2005090577A1 Expression of nitrille hydratases in a two-vector expression system
09/29/2005WO2005090576A1 Dna construct for preventing pertussis infection
09/29/2005WO2005090575A1 Glycosylation variants of ricin-like proteins
09/29/2005WO2005090574A1 Vascular endothelial growth inhibiting gene
09/29/2005WO2005090573A2 Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function
09/29/2005WO2005090572A2 Compositions and methods for treating pancreatic cancer
09/29/2005WO2005090571A1 Vglut-specific dsrna compounds
09/29/2005WO2005090570A1 Therapeutic compositions and methods for treating diseases that involve angiogenesis
09/29/2005WO2005090569A1 Cancer and testis vsm1 and vsm2 nucleic acids, proteins and uses thereof
09/29/2005WO2005090568A2 Promoter chain reaction
09/29/2005WO2005090567A1 Method and device for purifying nucleic acids
09/29/2005WO2005090566A2 Ligational encoding using building block oligonucleotides
09/29/2005WO2005090565A1 Dna array and method of detecting single nucleotide polymorphism
09/29/2005WO2005090564A1 Gene promoting vascular endothelial cell growth
09/29/2005WO2005090563A1 Solvent for dissolving nucleic acid, nucleic acid-containing solution and method of preserving nucleic acid
09/29/2005WO2005090562A1 Sequence capable of accelerating gene expression at moderately low temperature
09/29/2005WO2005090561A1 Method of screening activation inhibitor for macrophage cell
09/29/2005WO2005090559A1 Methods and compositions involving s-ship promoter regions
09/29/2005WO2005090557A1 Method of proliferating pluripotent stem cell
09/29/2005WO2005090552A2 Method of engineering a cytidine monophosphate-sialic acid synthetic pathway in fungi and yeast
09/29/2005WO2005090549A1 Cell culture microwell
09/29/2005WO2005090405A1 Subtype of humanized antibody against interleukin-6 receptor
09/29/2005WO2005090392A1 Tat-based tolerogen compositions and methods of making and using same
09/29/2005WO2005090381A1 Set1 proteins and uses therefor
09/29/2005WO2005089929A2 Modified surfaces as solid supports for nucleic acid purification
09/29/2005WO2005089812A2 Novel antibiotic alternatives
09/29/2005WO2005089811A1 Materials for treating vascular leakage in the eye
09/29/2005WO2005089801A1 Method of preventing ultraviolet ray-induced apoptosis
09/29/2005WO2005089800A1 PHARMACEUTICAL COMPOSITION CONTAINING hsHRD3
09/29/2005WO2005089735A2 Compositions and methods for treating lung cancer
09/29/2005WO2005089539A1 Transgenic model for alzheimer’s disease
09/29/2005WO2005089520A2 Methods and compositions relating to neuronal cell and tissue differentiation
09/29/2005WO2005089471A2 Increased stress tolerance and enhanced yield in plants
09/29/2005WO2005089443A2 Combinatorial methods and compositions for treatment of melanoma
09/29/2005WO2005089411A2 Tissue products from animals lacking functional alpha 1,3 galactosyl transferase
09/29/2005WO2005089287A2 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
09/29/2005WO2005089285A2 Methods and constructs for expressing polypeptide multimers in eukaryotic cells using alternative splicing
09/29/2005WO2005089268A2 Compositions and methods for optimizing cleavage of rna by rnase h
09/29/2005WO2005089252A2 Methods and compositions for the treatment of obesity
09/29/2005WO2005089247A2 Antisense composition and method for treating cancer
09/29/2005WO2005089229A2 Vpac1 selective antagonists and their pharmacological methods of use
09/29/2005WO2005089198A2 Transgenic soybean seeds having reduced activity of lipoxygenases
09/29/2005WO2005089182A2 Improved bacterial host cell for the direct expression of peptides
09/29/2005WO2005089148A2 Delivery of genes encoding short hairpin rna using receptor-specific nanocontainers
09/29/2005WO2005089123A2 Therapeutic anti-cancer dna
09/29/2005WO2005089122A2 Animals with reduced body fat and increased bone density
09/29/2005WO2005089093A2 Improved expression systems with sec-system secretion
09/29/2005WO2005089047A2 Glycosylated glucocerebrosidase expression in fungal hosts
09/29/2005WO2005089038A2 Method for cloning, expression and purification of the amyloid polypeptide from human pancreatic islets
09/29/2005WO2005078076A3 Tpl2 and its expression
09/29/2005WO2005073364A3 Advanced microorganism for producing 1,2-propanediol
1 ... 1938 1939 1940 1941 1942 1943 1944 1945 1946 1947 1948 1949 1950 1951 1952 1953 1954 1955 1956 1957 1958 ... 4023